{"ticker": {"uuid": "39710d78-680b-4c8d-83bb-c7b83726a3b0", "symbol": "TEVA", "name": "Teva Pharmaceutical Industries Limited", "exchange": "TLV", "country": "IL", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "How Teva\u2019s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T23:41:56+00:00", "published_display": "22 Jun 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T18:24:35+00:00", "published_display": "21 Jun 2026 18:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNN1RvT0lwcEF6N09fMWNybGtjaUo5OVlZSHhPMTBsS2Y1SkRwZUphcmtkSV80c2htUmNrcXJzSzI0STZkMER1MDhzektLd3BncXMxdHFpUHRpUVNJMEdUc1BHNHBhNzl4LW9ORVVWcURXWkhpYTFqNWFLRnNPenVVWUl3a0pmeHU5SG9NZ0hPb2pselJBOGJzWVJSc1VnbGJlU1ZYQ2I5TEVsMi1PMjN1U2Vpc0RNdDVqdXdvVWVfLTZ1MVVrWjJXd0ZCWDBEdw?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-21T11:16:42+00:00", "published_display": "21 Jun 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Industries Ltd (TEVA) Shares Fall 3.3% -- GF Value Says Still Overvalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNUGQ0RC1sTlkzZmh5alVfbDVwOHRXOEFxUmp5WU1xbE5vMklCRnBTbGJCZ216bXNZMFI4eHJvM3RrWUlvMlVoQTFsY3pvVWVncW01alRDQ0o1NW5xN0FNR1dsRERFOFBweXV4OUpwX29QaEpPZkRiTWgzZFlRWHB3ODZuTEVDckZDWDczU1R4amJrSEloRXlWN284NW8wWUxIT3dsV19JZVZyM3JqR0lZQjY0MFViZmFqei1RVlMzbi1wa21nY1ZiM19jV1phU2JrclE?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-18T21:54:46+00:00", "published_display": "18 Jun 2026 21:54", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Teva Pharmaceutical Industries Stock Fell Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONGEtYWlVTUFNRVNUR0dIYjN2NnVUTW5xWGg2eGVjdjEtckxQaXEyZ2FobDUteHJ0V3BsNEFNSXcyUjNNMUFJZlppeVhUTUJvNUNyclpSUmx5b1NDM2ZoYTYwUHNOdEw0WkhRMTVsbjhtQU1jYUwyUHFPM3BYTTBoanRMM0pSUjdud3BFVmdkODYyRGRFOEtxYg?oc=5", "source_name": "Moomoo", "published_at": "2026-06-18T17:35:53+00:00", "published_display": "18 Jun 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solid Earnings Reflect Teva Pharmaceutical Industries' (NYSE:TEVA) Strength As A Business", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWVdsdW9nOG5hUjhYbTU5WTZxLWVzNVUwa3hDb1c3SDIxZkt0Z0tTMmJIT01mSno4b3pXLTRMemZJS3VzUVJYVUN6dHg1VEF3OHJUeEl0UmpnTnMwR013VkNlb0doZ0NPMHlQVmlZVXNtRVJkSmpPRUZLV0tzZy15WnJBZDJRUlVhaTlNWTJLakhpSElZS1BOUGFBem01UFpwcTJsNzRHVnlnYlpLTkNvOQ?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Teva Pharmaceutical Industries Limited (TEVA) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOQjROTkEtbVZuZjZSbWtuM2EtRnBSSlk0NW9KaGVSckFtazdPdXg3V2RmTGRnVGhaVll3MF9qZHJrLWVnWnZCdTJ0MnBXQXR3YjRaam9PNkxfakZrRllJVnZjOTFmZHlpR1R1NEpKQnJUMHp6QUxuTDUzV1B4OVp4QU9Wckcybm9qSndya19HYklid2Zid3BfbWZ3Y2NTemZWaUpVb3ctcEUxbEM2?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxONkdPdmtpWERmdEdwbGFreXF2V095Yi0tZjM1dWZUdXF5WnFpNG1iMVBueHpBclQ1b2ZQSG5ZZS1iVFJCNW82emVjUWxqM2RwcFdMbXJfWjVlSmQxdEZZOGJOQWVMQktFclBqaWEyZC1peW40V3k1VV9GVEhNczB1MDNoWW5aUjN6NlpKNkJRUXNKejlKdXZvLTl3NnVYWEM2bWpfRkdEY2R5a0U?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTm9RcVFZWWZ2T3NXYzZ6RklSVzRTZ2x4SlZtMXQ4VUtFUHVtc25zNllPWXhFVDVjSDJTaEFQeU1HUUlfQ1dqQnhadkJvbDBSa2VmeVFnZ3hweVFGeTFNMGpsVmVoMDlsaDVaeEZNaml5WGpsbDJYQkJyTFVELUJGOFZqUEFuR1ZBVWlvY0hXZWlBT2YtMTVUOHRvVGJaenB3NnRlU2dNTzI4Q1d2M2NuazNRY0oxZDI3SGdHUUwwUG1fZGZ6?oc=5", "source_name": "Reuters", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPQ0VkT2I0bFpyZ3YtZGltMmZnVWRuVHhfQlU3N0FrczcxdTRMWTRnZ29ZMmx1S1d2UjFXbnh2Y2kwMm91a0E5RHk2QlNHc2RhNnllTVVlZFlrREJvN3p1bVZjZDVNUC1HQlR2RlRVeTNHbWd6azAwa2l1WU92clJxSUhqUF8zNVBoRDBWQVROSQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNYzVrN1h4MU1oVDRVcDlTdUNOZDFBSjlGbWthSk5haWFzNDFpaTB5UkJUb0k2ZlJDbnN1bW01WDBqQUQ1WUV3OEx5ZzcySXpjMkJrTUM5anpmWHd3NUwyZ3VPaW9reGpoNUFEbXkyOHpXbkFud1BIZEkyT2dCWFFHeVZRS21fbXcwXzdoTTdlNA?oc=5", "source_name": "Market source", "published_at": "2025-10-16T07:00:00+00:00", "published_display": "16 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical's branded drugs boost first quarter profit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQdFBDUEM0Q3g5YmR2MV81VEE3OWRBV1kwNGtuQjhVbC1IWk1iNlJjenVwWWpUaFdWLUkyWTVOc1RhWmRGaDlJNkZVM1BlOG8zTjlUVWZaVnFjdUFnZlV4UVRYYmRucUtuTW9wNDFhQjJpRVRfVEdPQnU1b3U0eXpIUl9hTk9YTVFnYzlwTUw5eGswWUloQnlkWEJoQVFDdndwM1BPWWVNa1Z1b0xUQ1FRZWVNaFRJUzMxbkE4TmYwUzU?oc=5", "source_name": "Reuters", "published_at": "2025-05-07T07:00:00+00:00", "published_display": "07 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Israel's Teva back in top pharmaceutical rankings", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE5GMXNoQ1Z5aUZneDVEWDF3UjlxOUpjUXlZdkhocXFOam5HUU5KMW00REhYVVNWX3ROWkpyMlRPT3ZFT3g4LThnQ0c1Wng2UnJOUGE0VmJObjVZSmNtekpfMVhNdUgzcnFYSTF0bw?oc=5", "source_name": "The Jerusalem Post", "published_at": "2024-04-16T07:00:00+00:00", "published_display": "16 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Israeli pharmaceutical stocks are down in the wake of Hamas attack", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPQ09NSGFMVTI0REFMUHoxLVRic1g3Vm1yNFhYUFJLb2x6cXRmSzBFMGF3ckFyZ0wzRDdJZnh1VmdSWFFjSXFFR0pNay1hdElQUnhVTU9zR0M3dkhETHdmUDFBOTEwNUxWY0ViLXNteW5qSUxuQzBEM2k4UWFvZmpsT3pFRmR0ZXRXRnFqbVNFRktXekxWYTBJQ2tONUdVdVBaSXR1X0dIazgySjdKZUJJQ0I4OENzdw?oc=5", "source_name": "MarketWatch", "published_at": "2023-10-09T07:00:00+00:00", "published_display": "09 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "How Teva\u2019s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T23:41:56+00:00", "published_display": "22 Jun 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-21T18:24:35+00:00", "published_display": "21 Jun 2026 18:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNN1RvT0lwcEF6N09fMWNybGtjaUo5OVlZSHhPMTBsS2Y1SkRwZUphcmtkSV80c2htUmNrcXJzSzI0STZkMER1MDhzektLd3BncXMxdHFpUHRpUVNJMEdUc1BHNHBhNzl4LW9ORVVWcURXWkhpYTFqNWFLRnNPenVVWUl3a0pmeHU5SG9NZ0hPb2pselJBOGJzWVJSc1VnbGJlU1ZYQ2I5TEVsMi1PMjN1U2Vpc0RNdDVqdXdvVWVfLTZ1MVVrWjJXd0ZCWDBEdw?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-21T11:16:42+00:00", "published_display": "21 Jun 2026 11:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Industries Ltd (TEVA) Shares Fall 3.3% -- GF Value Says Still Overvalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNUGQ0RC1sTlkzZmh5alVfbDVwOHRXOEFxUmp5WU1xbE5vMklCRnBTbGJCZ216bXNZMFI4eHJvM3RrWUlvMlVoQTFsY3pvVWVncW01alRDQ0o1NW5xN0FNR1dsRERFOFBweXV4OUpwX29QaEpPZkRiTWgzZFlRWHB3ODZuTEVDckZDWDczU1R4amJrSEloRXlWN284NW8wWUxIT3dsV19JZVZyM3JqR0lZQjY0MFViZmFqei1RVlMzbi1wa21nY1ZiM19jV1phU2JrclE?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-18T21:54:46+00:00", "published_display": "18 Jun 2026 21:54", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Teva Pharmaceutical Industries Stock Fell Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxONGEtYWlVTUFNRVNUR0dIYjN2NnVUTW5xWGg2eGVjdjEtckxQaXEyZ2FobDUteHJ0V3BsNEFNSXcyUjNNMUFJZlppeVhUTUJvNUNyclpSUmx5b1NDM2ZoYTYwUHNOdEw0WkhRMTVsbjhtQU1jYUwyUHFPM3BYTTBoanRMM0pSUjdud3BFVmdkODYyRGRFOEtxYg?oc=5", "source_name": "Moomoo", "published_at": "2026-06-18T17:35:53+00:00", "published_display": "18 Jun 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solid Earnings Reflect Teva Pharmaceutical Industries' (NYSE:TEVA) Strength As A Business", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQWVdsdW9nOG5hUjhYbTU5WTZxLWVzNVUwa3hDb1c3SDIxZkt0Z0tTMmJIT01mSno4b3pXLTRMemZJS3VzUVJYVUN6dHg1VEF3OHJUeEl0UmpnTnMwR013VkNlb0doZ0NPMHlQVmlZVXNtRVJkSmpPRUZLV0tzZy15WnJBZDJRUlVhaTlNWTJLakhpSElZS1BOUGFBem01UFpwcTJsNzRHVnlnYlpLTkNvOQ?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Teva Pharmaceutical Industries Limited (TEVA) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOQjROTkEtbVZuZjZSbWtuM2EtRnBSSlk0NW9KaGVSckFtazdPdXg3V2RmTGRnVGhaVll3MF9qZHJrLWVnWnZCdTJ0MnBXQXR3YjRaam9PNkxfakZrRllJVnZjOTFmZHlpR1R1NEpKQnJUMHp6QUxuTDUzV1B4OVp4QU9Wckcybm9qSndya19HYklid2Zid3BfbWZ3Y2NTemZWaUpVb3ctcEUxbEM2?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxONkdPdmtpWERmdEdwbGFreXF2V095Yi0tZjM1dWZUdXF5WnFpNG1iMVBueHpBclQ1b2ZQSG5ZZS1iVFJCNW82emVjUWxqM2RwcFdMbXJfWjVlSmQxdEZZOGJOQWVMQktFclBqaWEyZC1peW40V3k1VV9GVEhNczB1MDNoWW5aUjN6NlpKNkJRUXNKejlKdXZvLTl3NnVYWEM2bWpfRkdEY2R5a0U?oc=5", "source_name": "Market source", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNTm9RcVFZWWZ2T3NXYzZ6RklSVzRTZ2x4SlZtMXQ4VUtFUHVtc25zNllPWXhFVDVjSDJTaEFQeU1HUUlfQ1dqQnhadkJvbDBSa2VmeVFnZ3hweVFGeTFNMGpsVmVoMDlsaDVaeEZNaml5WGpsbDJYQkJyTFVELUJGOFZqUEFuR1ZBVWlvY0hXZWlBT2YtMTVUOHRvVGJaenB3NnRlU2dNTzI4Q1d2M2NuazNRY0oxZDI3SGdHUUwwUG1fZGZ6?oc=5", "source_name": "Reuters", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPQ0VkT2I0bFpyZ3YtZGltMmZnVWRuVHhfQlU3N0FrczcxdTRMWTRnZ29ZMmx1S1d2UjFXbnh2Y2kwMm91a0E5RHk2QlNHc2RhNnllTVVlZFlrREJvN3p1bVZjZDVNUC1HQlR2RlRVeTNHbWd6azAwa2l1WU92clJxSUhqUF8zNVBoRDBWQVROSQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNYzVrN1h4MU1oVDRVcDlTdUNOZDFBSjlGbWthSk5haWFzNDFpaTB5UkJUb0k2ZlJDbnN1bW01WDBqQUQ1WUV3OEx5ZzcySXpjMkJrTUM5anpmWHd3NUwyZ3VPaW9reGpoNUFEbXkyOHpXbkFud1BIZEkyT2dCWFFHeVZRS21fbXcwXzdoTTdlNA?oc=5", "source_name": "Market source", "published_at": "2025-10-16T07:00:00+00:00", "published_display": "16 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teva Pharmaceutical's branded drugs boost first quarter profit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQdFBDUEM0Q3g5YmR2MV81VEE3OWRBV1kwNGtuQjhVbC1IWk1iNlJjenVwWWpUaFdWLUkyWTVOc1RhWmRGaDlJNkZVM1BlOG8zTjlUVWZaVnFjdUFnZlV4UVRYYmRucUtuTW9wNDFhQjJpRVRfVEdPQnU1b3U0eXpIUl9hTk9YTVFnYzlwTUw5eGswWUloQnlkWEJoQVFDdndwM1BPWWVNa1Z1b0xUQ1FRZWVNaFRJUzMxbkE4TmYwUzU?oc=5", "source_name": "Reuters", "published_at": "2025-05-07T07:00:00+00:00", "published_display": "07 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Israel's Teva back in top pharmaceutical rankings", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE5GMXNoQ1Z5aUZneDVEWDF3UjlxOUpjUXlZdkhocXFOam5HUU5KMW00REhYVVNWX3ROWkpyMlRPT3ZFT3g4LThnQ0c1Wng2UnJOUGE0VmJObjVZSmNtekpfMVhNdUgzcnFYSTF0bw?oc=5", "source_name": "The Jerusalem Post", "published_at": "2024-04-16T07:00:00+00:00", "published_display": "16 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Israeli pharmaceutical stocks are down in the wake of Hamas attack", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPQ09NSGFMVTI0REFMUHoxLVRic1g3Vm1yNFhYUFJLb2x6cXRmSzBFMGF3ckFyZ0wzRDdJZnh1VmdSWFFjSXFFR0pNay1hdElQUnhVTU9zR0M3dkhETHdmUDFBOTEwNUxWY0ViLXNteW5qSUxuQzBEM2k4UWFvZmpsT3pFRmR0ZXRXRnFqbVNFRktXekxWYTBJQ2tONUdVdVBaSXR1X0dIazgySjdKZUJJQ0I4OENzdw?oc=5", "source_name": "MarketWatch", "published_at": "2023-10-09T07:00:00+00:00", "published_display": "09 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 64, "total_relevant": 14, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 8, "score": 52, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 5.85, "count": 10}, {"event": "earnings", "label": "Earnings", "weight": 2.35, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 9432.0, "latest_week": "2026-06-19", "one_week_move": -7.3, "four_week_move": -6.1, "twelve_week_move": 2.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.318334, "market_dynamics_buy_signal": false, "relative_strength": 1.590761, "fair_value_gap": 48.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 51.6354, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.3% over one week, -6.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 4}, {"label": "simplywall.st", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "Stocktwits", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "Seeking Alpha", "count": 1}, {"label": "The Jerusalem Post", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.3% over one week, -6.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "How Teva\u2019s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors"}], "updated_at": "2026-06-23T15:15:17.862827+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}